Evidence map›Paper›PMID 33375381›Full record

ArticleBiology2020

A New Transmission Route for the Propagation of the SARS-CoV-2 Coronavirus.

Antoine Danchin, Tuen Wai Ng, Gabriel Turinici

Abstract read
In one paragraph

Article in Biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. A systematic review on the occurrence, fate, and remediation of SARS-CoV-2 in wastewater.International journal of environmental science and technology : IJEST · 2023
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Antoine DanchinInstitut Cochin, INSERM U1016-CNRS UMR8104-Université de Paris, 75006 Paris, France.ORCID 0000-0002-6350-5001
Tuen Wai NgDepartment of Mathematics, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.ORCID 0000-0002-3985-5132
Gabriel TuriniciCEREMADE UMR 7434 CNRS, Université Paris Dauphine-PSL, 75016 Paris, France.ORCID 0000-0003-2713-006X

Funding

Research Grants Council, University Grants Committee 17306019Research Grants Council, University Grants Committee 17307420
6 · The paper itself

Abstract

backgroundStarting late 2019, a novel coronavirus spread from the capital of the Hubei province in China to the rest of the country, then to most of the world. To anticipate future trends in the development of the pandemic, we explore here, based on public records of infected persons, how variation in the virus tropism could end up in different patterns, warranting a specific strategy to handle the epidemic.

methodsWe use a compartmental model to describe the evolution of an individual through several possible states: susceptible, infected, alternative infection, detected, and removed. We fit the parameters of the model to the existing data, taking into account significant quarantine changes where necessary.

resultsThe model indicates that Wuhan quarantine measures were effective, but that alternative virus forms and a second propagation route are compatible with available data. For the Hong Kong, Singapore, and Shenzhen regions, the secondary route does not seem to be active.

conclusionsHypotheses of an alternative infection tropism (the gut tropism) and a secondary propagation route are discussed using a model fitted by the available data. Corresponding prevention measures that take into account both routes should be implemented to the benefit of epidemic control.

Indexed as

contaminationcoronaviruscoronavirus propagationCOVID-19epidemic modelSARSSARS-CoV-2

Identifiers

PMID33375381
PMCPMC7823892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.